ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

Et2’s Referral Guidelines

July 23, 1993

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

April 8, 2005

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978